Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Dec 06, 2023 4:51pm
139 Views
Post# 35771838

Also keep in focus the NDA (new drug application) cos' we

Also keep in focus the NDA (new drug application) cos' we have NO IDEA what the application of that drug will be for and we know one thing, it is NOT a generic which typically comes with lower margins.   Will the momentum indicator keep the uptrend going tomorrow?  If it does I will post screen shot of it here.   Institutionals, ala ITG Virtu are skinning uninformed retail shareholders alive for the moment and getting a pile of litterally free shares.  

alleyeonme...my disclosure...just over 1.5 million shares, TFSA stuffed to the max and sleeping very well at night as well.   The current b.s. is worth the 'weight'.  
<< Previous
Bullboard Posts
Next >>